New York, June 30, 2020 (GLOBE NEWSWIRE) -- announces the release of the report "Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025" -

Global regenerative medicine market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function.They are also being used to create solutions for organs that become permanently damaged.

These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.
Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The global regenerative medicine market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region.The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others.

Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases.Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical.

The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.
Major players operating in the global regenerative medicine market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

• To analyze and forecast the market size of global regenerative medicine market.
• To classify and forecast global regenerative medicine market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
• To identify drivers and challenges for global regenerative medicine market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global regenerative medicine market.
• To conduct pricing analysis for global regenerative medicine market.
• To identify and analyze the profile of leading players operating in global regenerative medicine market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers which could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across the globe.
The analyst calculated the market size of global regenerative medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Regenerative medicine manufacturers, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to regenerative medicines
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Therapy:
o Cell-Based Immunotherapy & Cell Therapy
o Gene Therapy
o Tissue-Engineering
o Immunomodulation Therapy
o Blood Transfusion
o Bone Marrow Transplantation
o Plasma Rich Plasma Therapy
o Prolotherapy
o Others
• Market, By Application:
o Musculoskeletal Disorders
o Wound Care
o Oncology
o Neurology
o Ocular Disorders
o Diabetes
o Cardiology
o Others
• Market, By Material:
o Synthetic Material
- Biodegradable Synthetic Polymers
- Scaffold
- Artificial Vascular Graft Materials
- Hydrogel Materials
o Biologically Derived Material
- Collagen
- Xenogeneic Material
o Genetically Engineered Material
- Genetically Manipulated Cells
- 3D Polymer Technology
- Transgenic
- Fibroblast
- Neural Stem Cells
- Gene-activated Matrices
o Pharmaceutical
- Small Molecules
- Biologics
• Market, By Cell:
o Autologous
o Allogenic
• Market, By Product:
o Biologic
o Cell -based Medical Devices
o Biopharmaceutical
o Biomaterial
• Market, By Technique:
o Microfracture
o Mosaicplasty
• Market, By Distribution Channel:
o Hospitals
o Clinics
o Online
o Others
• Market, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
o Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
o Middle East & Africa
- South Africa
- Saudi Arabia
o South America
- Brazil
- Argentina
- Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global regenerative medicine market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


US: (339)-368-6001
Intl: +1 339-368-6001